FDA’s Technology Modernization Action Plan
The plan describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data, and analytics—to advance FDA’s public health mission.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
UNFI Voluntarily Recalls Arla Apetina Marinated Feta & Olives in Oil, Pitted Because of Possible Health Risk
Food & Beverages
Innoveix Pharmaceuticals, Inc. Issues Voluntary Recall of all Sterile Compounded Drug Products Due to a Lack of Sterility Assurance
Fisherman’s Pride Processors Issues Recall of Shrimp Product Due to Misbranding and Undeclared Milk and Soy Allergens
Food & Beverages
The FDA’s Critical Focus on Women’s Health
The FDA takes very seriously its long-standing commitment and approach to women’s health.
FDA’s Comprehensive Response to HIV — Part II
FDA plays a pivotal role in advancing HIV therapies in underserved global markets through the President’s Emergency Plan for AIDS Relief (PEPFAR).
FDA’s Comprehensive Response to HIV — Part I
A multidisciplinary approach helps spur the development of effective treatments and approval of an expanding number of HIV drugs and drug combinations.
Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings - Labeling Considerations
Investigational In Vitro Diagnostics in Oncology Trials: Streamlined Submission Process for Study Risk Determination Guidance for Industry